Key Drivers
- Strong free cash flow
- Elevated debt load
- Margin compression
AIAI Summary
PBH is a leveraged recovery story—not a defensive consumer-health bargain—where upside depends on restoring Clear Eyes availability and converting strong free cash flow into debt reduction, while further integration missteps or acquisitions could pressure already-weakened interest coverage.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong free cash flow
- •Elevated debt load
- •Margin compression
PBH offers strong cash flow and liquidity, but rising acquisition-driven leverage, weaker recent margins, and higher valuation multiples warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Support test
- •Oversold momentum
PBH is in a strong last-month downtrend, testing $45 support; oversold RSI may spark a bounce, but a break below $45 would remain bearish.
Selling accelerated after
Sentiment & News
Key News Insights:
- •Valuation comparisons
- •Barclays presentation
- •Clear Eyes recall
PBH drew valuation and investor attention but faces near-term reputational risk from a Clear Eyes recall.
The recall may pressure sentiment, while investor engagement supports visibility
Similar Companies in Healthcare
Other companies in the same sector with AI ratings